# LMWH to Prevent Preeclampsia and Fetal Growth Restriction

> **NCT00260520** · — · TERMINATED · sponsor: **University of Florence**

## Conditions studied

- Preeclampsia

## Interventions

- **DRUG:** Dalteparin

## Key facts

- **NCT ID:** NCT00260520
- **Lead sponsor:** University of Florence
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2002-01
- **Primary completion:** —
- **Final completion:** 2003-12
- **Target enrollment:** — (—)
- **Last updated:** 2006-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00260520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00260520, "LMWH to Prevent Preeclampsia and Fetal Growth Restriction". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00260520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*